Clinical Trial Update: Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR) [Phase 1]

View source ↗

Summary

This document reports the completion status of a Phase 1 clinical trial of IMAB027 in patients with recurrent advanced ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• IMAB027

Snippet

Sponsor: Ganymed Pharmaceuticals GmbH | Conditions: Ovarian Cancer | Phase 1 | Status: COMPLETED